Old Drugs, New Tricks

In recent years two Scandinavian studies have shown that fibrates (lipid-lowering drugs) reduce atheroma plaque formation , through an unknown mechanism. Bart Staels and Professor Jean-Charles Fruchart (INSERM 325, Lille 2 University and Lille Pasteur Institute), in collaboration with the teams headed by Jacques Maclouf (INSERM 348, directed by Sylviane Levy-Toledano) and Alain Tedgui (INSERM 141, directed by Bernard Levy), have now discovered why : fibrates have an anti-inflammatory effect on vessel walls.

Fibrates, a class of drugs that reduce blood fat levels, have been used for about a decade in the treatment of some forms of hyperlipidemia and atherosclerosis. Fibrates bind to PPARa, a receptor present in the liver and involved in fatty acid breakdown . PPARa acts as a messenger, allowing the body to adapt to its nutritional environment (especially ingestion of large amounts of fat). Fibrates, synthetic compounds that bind to this receptor, stimulate PPARa activity and thereby reinforce its lipid-lowering action.

The INSERM researchers showed that PPARa receptors are also present in vascular muscle cells, which participate in the formation of atheroma plaque and restenosis after angioplasty . These vascular PPARa receptors were found to inhibit the inflammatory response of the vascular wall which leads to atheroma plaque formation (see inset). Fibrates, by activating PPARa, inhibit the production of inflammatory cytokines such as interleukin-6 (IL-6) and prostaglandin by vascular muscle cells in vitro. They also inhibit the induction of an enzyme called Cox-2 (cyclooxygenase), which serves as a marker of vascular cell inflammation.

The mechanism of action of these PPARa receptors in the vascular wall was also elucidated. The receptors exert at least part of their anti-inflammatory effect by interfering with a signaling pathway called NFkB, which is also activated during inflammatory cytokine production. PPARa inhibits the inflammatory response by

Contact: Jean-Charles Fruchart
33 3 20 87 73 52
French National Institute for Health and Medical Research (INSERM)

Page: 1 2 3

Related medicine news :

1. Even in an era of HAART Drugs, HIV patients are vulnerable to opportunistic infections

Post Your Comments:

(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... $3,296 in property taxes a year. In some states—like New York, New Jersey, ... By contrast, many overseas retirement havens have extremely low property-tax rates, which contributes ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
Breaking Medicine Technology:
Cached News: